jueves, 26 de noviembre de 2009

The Worst Drug Company Marketing Techniques (VII): AVENTIS

In May of this year, Aventis Pharmaceutical, a subsidiary of the pharmaceutical company Sanofi-Aventis, resolved charges that it intentionally misreported drug prices for anti-inflammatory nasal sprays, thereby lowering its rebate payments to Medicaid. In its settlement with the Justice Department, the company committed to pay a $95.5 million fine.
Ver anteriores...

No hay comentarios: